Drugs / Adsorbed cell-free leukiche (three-component) combination vaccine
Adsorbed cell-free leukiche (three-component) combination vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05189548 | Dec 2021 → Apr 2022 | — | Changchun BCHT Biotechnology Co. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adsorbed cell-free leukiche (three-component) combination vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05189548 ↗ |
| Modality | Vaccine | “adsorbed cell-free leukiche (three-component) combination vaccine” NCT05189548 ↗ |